Gujarat Kidney & Super Speciality IPO

Lot size and investment

Reservation

QIB

1,65,00,000 shares (75.00% of the Offer)

NII

33,00,000 shares (15.00% of the Offer)

Retail

22,00,000 shares (10.00% of the Offer)

Current GMP

₹55

—

Estimated listing price

₹169

Issue price ₹114

Highest

₹55

4 Jan

Lowest

₹55

4 Jan

GMP by day (₹ per share)

GMP is an unofficial indicator from an unregulated market. It is shown for information only and is not a prediction of the listing price or a recommendation to apply.

P/E Ratio

61.62

EPS (₹)

1.85

RoCE

37.65

RoNW

36.61

PAT Margin

23.61

Separate pre- and post-issue P/E are not available for this IPO; the P/E shown is as disclosed for the issue.

Peers are other recent IPOs from the same industry, closest in issue size. Ratios are as disclosed at the time of each issue. This is not the listed-peer table from the offer document.

Gujarat Kidney & Super Speciality Hospital was established with the aim of providing advanced and affordable healthcare services, particularly in nephrology and critical care. Over the years, the hospital has built a strong reputation in Gujarat for its specialised treatment of kidney-related diseases, dialysis services, and multi-speciality care. The institution is promoted by experienced medical professionals and healthcare entrepreneurs who bring deep domain expertise and a patient-centric approach. With a focus on quality treatment and modern medical infrastructure, the hospital has expanded its capabilities to cater to a growing patient base across the region. The hospital offers a wide range of services including nephrology, urology, cardiology, intensive care, and other super speciality treatments. It is equipped with advanced dialysis units, operation theatres, and diagnostic facilities to support comprehensive patient care. The business model is primarily service-driven, generating revenue through consultations, procedures, diagnostic services, and inpatient care. By maintaining a balance between affordability and quality, the hospital aims to serve both urban and semi-urban populations while building long-term trust and relationships with patients.

Objects of the issue

1. Proposed acquisition of Parekhs Hospital at Ahmedabad.₹77 Cr
2. Part-payment of purchase consideration for the already acquired “Ashwini Medical Centre”.₹12.4 Cr
3. Funding of capital expenditure requirements of the Company towards setting up of a new hospital in Vadodara.₹30.1 Cr
4. Buying robotics equipment for our hospital Gujarat Kidney & Super Speciality hospital in Vadodara location.₹6.83 Cr
5. Full or part repayment and/or prepayment of certain outstanding secured borrowings availed by the Company₹1.2 Cr
6. Funding inorganic growth through unidentified acquisitions and General Corporate Purposes.₹87.44 Cr
7. Acquisition of additional shareholding in the subsidiary namely “Harmony Medicare Private Limited” at Bharuch₹10.78 Cr

Promoters and shareholding

Anitaben Yashwantsinh Bharpoda, Bhartiben Pragnesh Bharpoda, Pragnesh Yashwantsinh Bharpoda, Yashwantsingh Motisinh Bharpoda

Promoter holding, pre-issue

99.1%

Promoter holding, post-issue

71.45%